FCM
KNTE

Farallon Capital Management’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History

Farallon Capital Management’s Portfolio KNTE Stock Details KNTE Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-250,000
Closed -$7.79M – 319
2021
Q1 		$7.79M Hold
250,000
– – 0.04% 155
2020
Q4 		$9.95M Buy
+250,000
New +$9.95M 0.06% 107